MAM
Ducati India appoints Bipul Chandra as the new managing director
MUMBAI: Luxury motorcycle brand Ducati today announced a change in its management structure. With Mr. Sergi Canovas moving to an international role, Ducati Motor Holding announced Mr. Bipul Chandra as the new Managing Director of the India operations.
Mr. Chandra in his earlier role, was Ducati India’s Sales Director, and has now assumed the position of Managing Director for the company. In his new role, Mr. Chandra will be responsible for spearheading Ducati’s business growth and network expansion in the country.
Mr. Bipul Chandra, Managing Director of Ducati India said, “It’s an honor to be associated with a leading global superbike manufacturer. It was an absolute pleasure working with the India team and I look forward to newer challenges in my role as the Managing Director for Ducati in India.”
With more than 2 decades of experience in the auto industry, Mr. Chandra has played an instrumental role in steering the growth and expansion of brands such as Ashok Leyland, Tata Motors and Bajaj Auto Ltd. Being an industry veteran, Mr. Chandra has excellent analytical skills, system & process orientation, strong inter-personal skills and ability to work in a multicultural & geographical environment.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
